Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study.

Rasmussen, Lotte; Andersen, Jacob Harbo; Karlstad, Øystein; Giunta, Diego Hernan; Linder, Marie; Furu, Kari; Pottegård, Anton.

Afiliação

Rasmussen L; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Andersen JH; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Karlstad Ø; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Giunta DH; Centre for Pharmacoepidemiology, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Linder M; Centre for Pharmacoepidemiology, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Furu K; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Pottegård A; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.

Diabetes Obes Metab ; 2024 Aug 20.

Article em En | MEDLINE | ID: mdl-39164856